Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed.
    Difference
    1%
    Check dated 2026-11-08T15:06:09.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changes from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:54:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    An NIH announcement about updated terminology during the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T15:18:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T18:14:41.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the 403 Forbidden page is otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-11T18:44:28.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Access to the study record now results in a 403 Forbidden page, indicating the resource is blocked. The new 403 page content includes HTML boilerplate and a simple notice, replacing the previous in-page study details.
    Difference
    17%
    Check dated 2026-09-20T19:23:53.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.